financetom
Business
financetom
/
Business
/
KB Home Seeing Improved Fiscal Q2-to-Date Orders, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KB Home Seeing Improved Fiscal Q2-to-Date Orders, BofA Says
Mar 10, 2026 8:13 PM

11:42 AM EDT, 03/25/2025 (MT Newswires) -- KB Home's ( KBH ) fiscal Q2-to-date orders improved after the company cut base home prices in certain communities to stimulate demand, BofA Securities said in a Tuesday note.

The company reported fiscal Q1 earnings Monday of $1.49 per diluted share, down from $1.76 a year earlier, as revenue fell to $1.39 billion from $1.47 billion.

The homebuilder lowered its 2025 revenue outlook to $between $6.6 billion and $7 billion, from $7 billion to $7.5 billion previously, after fiscal Q1 orders fell short. In mid-February, KB Home ( KBH ) reduced base prices by an average of $15,000-$16,000 in select communities, which helped net orders improve in the past five weeks, BofA said.

KB Home ( KBH ) also adjusted its margin expectations following the price reductions. The company forecasts a sequential decline in fiscal Q2 margins but expects them to improve in the second half of the year as it benefits from higher sales volumes.

BofA Securities lowered its price objective on KB Home ( KBH ) stock to $62 from $67 and maintained a neutral rating on the company.

Shares of KB Home ( KBH ) were down 3.6% in recent Tuesday trading.

Price: 59.59, Change: -2.20, Percent Change: -3.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved